ArticleDocumenta ophthalmologica. Advances in ophthalmology2026
The effect of physiological changes in estradiol hormone during the follicular phase of the menstrual cycle in healthy women on retinal ganglion cell function, retinal and optic nerve vascularization and structure.
Article in Documenta ophthalmologica. Advances in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to investigate the effects of estradiol changes occurring during the early follicular phase of the menstrual cycle on retinal ganglion cell function, retinal and optic nerve vascularity and structure in healthy adults using pattern electroretinography (PERG), optical coherence tomography (OCT), and optical coherence tomography angiography (OCTA).
methodsThe study included 26 healthy subjects with a visual acuity of 1.0. Serum hormone levels, intraocular pressure (IOP), cycloplegic spherical equivalent (SE), PERG, retinal nerve fiber layer (RNFL) thickness and OCTA measurements were evaluated. PERG tests were performed using the Metrovision Monpack system. Spectral-domain OCT (Topcon Corporation, Tokyo, Japan); OCTA (Optovue, Inc, Fremont, CA) devices were used. All tests were conducted on the 1st and 14th days of the menstrual cycle, and the results were compared.
resultsThe mean serum estradiol values on days 1 and 14 were 51 ± 19 ng/L and 304 ± 50 ng/L, respectively. PERG revealed no statistically significant differences in the amplitude or latency of the P50 and N95 waves between days 1 and 14. RNFL thickness did not differ significantly in the mean, superior, or inferior quadrants (p = 0.90, p = 0.85, and p = 0.39, respectively). OCTA analysis showed that peripapillary and macular vascular density values were similar between days 1 and 14 (p > 0.05). Correlation analysis revealed no significant relationship between electrophysiological parameters, RNFL thickness measurements, and retinal vascular densities (p > 0.05).
conclusionIn healthy women, no significant functional, vascular, or structural differences were observed in PERG, OCT, or OCTA parameters between low and high estradiol levels on days 1 and 14 of the menstrual cycle. Unlike the persistently low estradiol levels seen in menopause, physiological estradiol fluctuations during a healthy menstrual cycle do not cause functional, structural, or vascular changes in the optic nerve or retina.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.